American Shared Hospital Services

AMS

$2.69

Closing

▼-1.82%

1D

▲13.05%

YTD

Market cap

$16.88M

52 week high

$3.75

52 week low

$2.17

Volume

18

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

Market cap

$16.88M

Analysts' Rating

-

Price Target (Mean)

-

Total Analysts

0

P/E

39.78

Operating Margin

1.75%

Beta

0.66

Revenue Growth (Annual)

12.01%

52 week high

$3.75

52 week low

$2.17

Div. Yield

%

EPS Annual Growth

0.00

Note on Purification and Zakat

  • Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly). 
  • If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
  • For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them. 

Company Profile

American Shared Hospital Services is a provider of financial and turnkey solutions to cancer treatment centers, hospitals, and large cancer networks worldwide. The Company’s products include MR Guided Radiation Therapy Linacs, Advanced Linear Accelerators, Proton Beam Radiation Therapy Operations (PBRT), Brachytherapy systems, and through the Company’s GK Financing partnership with Elekta, the Leksell Gamma Knife product and services. The Gamma Knife radiosurgery equipment is a non-invasive treatment for malignant and benign brain tumors, vascular malformations, and trigeminal neuralgia (facial pain). The PBRT is an alternative to traditional external beam, photon-based radiation delivered by linear accelerators. PBRT treats prostate, brain, spine, head and neck, lung, breast, gastrointestinal tract, and pediatric tumors. The Company typically provides the equipment, as well as planning, installation, reimbursement and marketing support services.